3rd Quarter - Report

NATIONAL MARROW DONOR PROGRAM for NATIONAL MARROW DONOR PROGRAM

Firm
Client
Income
—
Expenses
$310,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Continued funding for the C.W. Bill Young Cell Transplantation Program. Increased funding to expand patient access to transplants. Increased medical research funding.

LobbyistCovered position, as disclosed
JESSICA KNUTSON —
ANNE SIMAYTIS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Transportation TRA

Donated bone marrow/cell transportation for life-saving transplant.

LobbyistCovered position, as disclosed
JESSICA KNUTSON —
ANNE SIMAYTIS —

Contacted: U.S. Customs & Border Protection; Transportation Security Administration (TSA)

Health Issues HCR

Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109. Clinical Trial Modernization Act, H.R. 3521, S. 4440. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials.

LobbyistCovered position, as disclosed
JESSICA KNUTSON —
ANNE SIMAYTIS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 4109 (119th), H.R. 3521 (119th), S. 4440 (119th), H.R. 5160 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.